Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 3 for:    HSP90 | "Pancreatic Neoplasms"

Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03095781
Recruitment Status : Recruiting
First Posted : March 30, 2017
Last Update Posted : May 22, 2020
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Exelixis
Information provided by (Responsible Party):
Bassel El-Rayes, Emory University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2023